Results

Total Results: 159 records

Showing results for "prostate cancer screening".
Users also searched for: psa

1. Prostate Cancer Screening | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/health-topics/prostate-cancer-screening

2. Prostate-Cancer-Test Research-Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-test_research-protocol.pdf
   October 14, 2011 - ] (OR text words “prostate cancer”, “prostatic cancer”, “prostate neoplasms”, “prostatic neoplasms” … of the prostate; levels may be elevated in association with other pathologies affecting the prostate … (prostate cancer antigen 3 [TIAB]) OR (prostatic cancer antigen 3 [TIAB]) OR DD3 antigen, human [ … test-specific set= 208 in PubMed Additionally - "Prostatic Neoplasms"[Mesh] OR "prostatic neoplasms … " OR "prostate neoplasms" OR "prostatic cancer" OR "prostate cancer" AND (nomogram OR (neural AND

3. Prostate-Cancer-Test Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
   April 01, 2013 - Cancer Executive Summary Background Cancer of the prostate is the second most common cancer and … prostate cancer screening using tPSA was to reduce the prevalence of advanced prostate cancer and … Screening, risk assessment, and the approach to therapy in patients with prostate cancer. … Randomized Study of Screening for Prostate Cancer. … Screening for prostate cancer: a review of the evidence for the U.S.

4. Prostate-Cancer-Therapies-Update Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
   December 01, 2014 - of the Prostate Risk Assessment (CAPRA). … Prostate-cancer screening--what the U.S. Preventive Services Task Force left out. … Why is prostate cancer screening so common when the evidence is so uncertain? … The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation … Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective

5. Prostate-Cancer-Therapies-Update Research-Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
   April 01, 2013 - on the effect of PSA screening on prostate cancer mortality. … cancer EMBASE (EMTREE) Neoplasms/ Prostate/ Prostatic Neoplasms/ Cancer* Carcinoma* Neoplasm … cancer Prostatic Neoplasms/ 2 Prostate cancer (prostat$.ti,ab. or Prostate/) AND (cancer.ti,ab. or … cancer “prostatic neoplasms/surgery”[mesh] or “prostatic neoplasms/therapy”[mesh] OR “prostatic neoplasms … /radiotherapy”[mesh] 2 Prostate cancer “prostatic neoplasms”[mesh] OR (prostat*[tiab] AND (neoplasm*

6. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/protocol
   September 12, 2019 - with prostate cancer have cancer confined to the prostate gland or clinically localized prostate cancer … Baseline PSA Gleason score Tumor index scores (e.g., Cancer of the Prostate Risk Assessment Score … EAU-ESTRO-SIOG Guidelines on Prostate Cancer. … Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. … of the Prostate Risk Assessment Score CLPC= clinically localized prostate cancer EAU= European Association

7. PCA3 Testing for the Diagnosis and Management of Prostate Cancer | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/prostate-cancer-test/research-protocol
   October 14, 2011 - Despite the publication of thousands of articles on PSA and prostate cancer screening, the value of early … OR text words “prostate cancer”, “prostatic cancer”, “prostate neoplasms”, “prostatic neoplasms”) AND … Prostate cancer screening practices in the general population at risk (men over the age of 50) may not … of the prostate; levels may be elevated in association with other pathologies affecting the prostate … - "Prostatic Neoplasms"[Mesh] OR "prostatic neoplasms" OR "prostate neoplasms" OR "prostatic cancer

8. Localized Prostate Cancer | Effective Health Care
   effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/05.html
   June 08, 2018 - Home Consumers Clinically Localized Prostate Cancer Prostate Cancer Archived … Cancer Page 5 of 24 How Is Prostate Cancer Found? … Prostate cancer is usually found during a routine exam or through screening. … screening tests that look for the disease during routine exams. … For those men that choose screening, two tests that may be used to detect prostate cancer are: PSA

9. Prostate-Cancer-Risk-Assessment-Genes Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
   July 01, 2012 - Prostate cancer: Current evidence weighs against population screening. … Screening for prostate cancer: An updated Cochrane systematic review. … Screening for prostate cancer: The controversy that refuses to die. … Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related … Screening for prostate cancer: A review of the evidence for the U.S.

10. Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Comparative Effectiveness Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/research-protocol
    March 29, 2013 - on the effect of PSA screening on prostate cancer mortality. … Screening for prostate cancer: a review of the ERSPC and PLCO trials. … cancer Prostatic Neoplasms/ 2 Prostate cancer (prostat$.ti,ab. or Prostate/) AND (cancer.ti, … cancer “prostatic neoplasms/surgery”[mesh] or “prostatic neoplasms/therapy”[mesh] OR “prostatic neoplasms … /radiotherapy”[mesh] 2 Prostate cancer “prostatic neoplasms”[mesh] OR (prostat*[tiab] AND (neoplasm

11. Multigene Panels in Prostate Cancer Risk Assessment | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-risk-assessment-genes/research
    July 03, 2012 - Initiated Jul. 3, 2012 Systematic Review Dec. 5, 2012 Disposition of Comments Report Multigene Panels in Prostate … Cancer Risk Assessment Systematic Review Archived July 3, 2012 Web Version [NLM Site] Download Main … cancer. … and full text screening. … All had poor discriminative ability for predicting risk of prostate cancer and/or distinguishing between

12. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
    January 01, 2010 - cancers? … Do changes in screening and management for prostate cancer resulting from use of PCA3 assays lead to … What is the cost-effectiveness of using PCA3 assays to guide screening and management for prostate cancer … Potential for clinically significant prostate cancers to be missed in individuals presumed to be at … While there are currently several guidelines addressing total PSA testing and prostate cancer screening

13. Therapies for Clinically Localized Prostate Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_clinician.pdf
    January 01, 2016 - Therapies for Clinically Localized Prostate Cancer Therapies for Clinically Localized Prostate Cancer … The Scandinavian Prostate Cancer Group-4 (SPCG-4) study (N = 695) and the Prostate Cancer Intervention … Prostate cancer–specific mortality: The SPCG-4 study found that RP reduced prostate cancer–specific … Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. … Prostate-specific antigen screening after 2012 US Preventive Services Task Force recommendations.

14. 04-E029-1 Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - screening. … Indeed, more than half of prostate cancers detected by PSA screening are expected to be early-stage, … of the Prostate Strategic Urologic Research Endeavor). … of the Prostate Urologic Research Endeavor (CaPSURE) database, 5 the National Cancer Database (NCDB) … Similarly, black patients with prostate cancer were at higher risk for death due to prostate cancer compared

15. PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
    April 01, 2013 - Cancer of the prostate is the second most common cancer and the second leading cause of cancer deaths … The prostate cancer antigen-3 gene (PCA3) has recently been found to be overexpressed in prostate cancers … of the prostate is the second most common cancer and the second leading cause of cancer deaths in men … Randomized Study of Screening for Prostate Cancer. … of the prostate is the second most common cancer and the second leading cause of cancer deaths in men

16. Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/prostate-cancer/

17. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - Therapies for Clinically Localized Prostate Cancer: Evidence Summary Comparative Effectiveness Review … Number 230 Therapies for Clinically Localized Prostate Cancer Evidence Summary Main Points … Prostate cancer mortality is infrequent in low-risk disease, and all-cause or prostate cancer mortality … Prostate cancer mortality and metastases were rare in all three groups. … Clinically Localized Prostate Cancer Evidence Report ECRI Institute,.

18. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - neoplasms OR "prostate cancer" AND Limits: Meta-Analysis OR prostatic neoplasms OR "prostate cancer … neoplasms OR "prostate cancer" AND "age factors"OR age [ti] OR ethnicityOR ethnic groups OR … neoplasms OR "prostate cancer" AND "hospital volume" OR "surgeon volume" OR "clinical competence" … neoplasms OR "prostate cancer" AND caseload* OR case load* OR case volume* NUMBER OF RESULTS … neoplasms OR "prostate cancer" AND prostate-specific antigen OR "tumor characteristics" OR "tumor

19. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - neoplasms OR "prostate cancer" AND Limits: Meta-Analysis OR prostatic neoplasms OR "prostate cancer … neoplasms OR "prostate cancer" AND "age factors"OR age [ti] OR ethnicityOR ethnic groups OR … neoplasms OR "prostate cancer" AND "hospital volume" OR "surgeon volume" OR "clinical competence" … neoplasms OR "prostate cancer" AND caseload* OR case load* OR case volume* NUMBER OF RESULTS … neoplasms OR "prostate cancer" AND prostate-specific antigen OR "tumor characteristics" OR "tumor

20. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/clinician
    January 21, 2016 - The Scandinavian Prostate Cancer Group-4 (SPCG-4) study (N = 695) and the Prostate Cancer Intervention … and reported data on prostate cancer–specific and all-cause mortality. … Prostate cancer–specific mortality : The SPCG-4 study found that RP reduced prostate cancer–specific … Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. … Prostate-specific antigen screening after 2012 US Preventive Services Task Force recommendations.